Aaron M. Ring

19.9k citations

68 papers · 8.9k · 7 hit papers · h-index 38

Impact in

Immunology top 0.5%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Phagocytosis and Immune Regulation
- Immunotherapy and Immune Responses
Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Immunology 38
- Immune Cell Function and Interaction 13
- Phagocytosis and Immune Regulation 13
- T-cell and B-cell Immunology 12
- Immunotherapy and Immune Responses 10
Molecular Biology 23
- Ion Transport and Channel Regulation 6

Co-authors: Irving L. Weissman (15 shared papers)K. Christopher García (13 shared papers)Roy L. Maute (6 shared papers)Sydney R. Gordon (6 shared papers)Andrew C. Kruse (6 shared papers)Jonathan M. Tsai (3 shared papers)Benson M. George (3 shared papers)Melissa McCracken (3 shared papers)
Journals: Proceedings of the National Academy of Sciences (8 papers)Nature (6 papers)Cell (4 papers)eLife (4 papers)Blood (2 papers)
Partner nations: United States India Germany

In The Last Decade

Aaron M. Ring

63 papers receiving 8.8k citations

Aaron M. Ring's Hit Papers

7 papers align trajectories log scale

A Forward Chemical Genetic Screen Reveals Gut Microbiota Metabolites That Modulate Host Physiology 2019 · 266 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Cell
2019 Cell
2018 Nature Structural & Molecular Biology
2017 Nature
2017 Nature Immunology
2013 Nature
2013 Nature

Peers

Countries citing papers authored by Aaron M. Ring

Since Specialization

Citations

This map shows the geographic impact of Aaron M. Ring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron M. Ring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron M. Ring more than expected).

Fields of papers citing papers by Aaron M. Ring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron M. Ring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron M. Ring. The network helps show where Aaron M. Ring may publish in the future.

Co-authors

The 25 scholars most cited alongside Aaron M. Ring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aaron M. Ring Line = papers co-authored together Aaron M. Ring links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity Nature ·Sydney R. Gordon, Roy L. Maute, Ben W. Dulken, Gregor Hütter, Benson M. George, Melissa McCracken, Rohit Gupta, Jonathan M. Tsai, Rahul Sinha, Daniel Corey, Aaron M. Ring, Andrew J. Connolly, Irving L. Weissman Hit paper breakdown →	2017	1706
2	Activation and allosteric modulation of a muscarinic acetylcholine receptor Nature ·Andrew C. Kruse, Aaron M. Ring, Aashish Manglik, Jianxin Hu, Kelly Hu, Katrin Eitel, Harald Hübner, Els Pardon, Céline Valant, Patrick M. Sexton, Arthur Christopoulos, Christian C. Felder, Peter Gmeiner, Jan Steyaert, William I. Weis, K. Christopher García, Jürgen Wess, Brian K. Kobilka Hit paper breakdown →	2013	722
3	Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy Nature Immunology ·Amira Barkal, Kipp Weiskopf, Kevin S. Kao, Sydney R. Gordon, Benyamin Rosental, Ying Ying Yiu, Benson M. George, Maxim Markovic, Nan Ring, Jonathan M. Tsai, Kelly M. McKenna, Po Y. Ho, Robin Z. Cheng, James Y. Chen, Layla J. Barkal, Aaron M. Ring, Irving L. Weissman, Roy L. Maute Hit paper breakdown →	2017	438
4	Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’ Nature ·Aron M. Levin, D.L. Bates, Aaron M. Ring, Carsten Krieg, Jack T. Lin, Leon Su, Ignacio Moraga, Miro E. Raeber, Gregory R. Bowman, Paul Novick, Vijay S. Pande, C. Garrison Fathman, Onur Boyman, K. Christopher García	2012	420
5	Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody Nature ·Aaron M. Ring, Aashish Manglik, Andrew C. Kruse, M.D. Enos, William I. Weis, K. Christopher García, Brian K. Kobilka Hit paper breakdown →	2013	414
6	Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies Science ·Kipp Weiskopf, Aaron M. Ring, Chia Chi M. Ho, Jens-Peter Volkmer, Aron M. Levin, Anne Kathrin Volkmer, Engin Özkan, Nathaniel B. Fernhoff, Matt van de Rijn, Irving L. Weissman, K. Christopher García	2013	382
7	Yeast surface display platform for rapid discovery of conformationally selective nanobodies Nature Structural & Molecular Biology ·Conor McMahon, Alexander S. Baier, Roberta Pascolutti, Marcin Wegrecki, Sanduo Zheng, Janice X. Ong, Sarah C. Erlandson, Daniel Hilger, Søren G. F. Rasmussen, Aaron M. Ring, Aashish Manglik, Andrew C. Kruse Hit paper breakdown →	2018	365
8	GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance Cell ·Harding H. Luan, Andrew Wang, Brandon K. Hilliard, Fernando O. de Carvalho, Connor Rosen, Amy M. Ahasic, Erica L. Herzog, Insoo Kang, Margaret A. Pisani, Shuang Yu, Cuiling Zhang, Aaron M. Ring, Lawrence H. Young, Ruslan Medzhitov Hit paper breakdown →	2019	354
9	Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging Proceedings of the National Academy of Sciences ·Roy L. Maute, Sydney R. Gordon, Aaron T. Mayer, Melissa McCracken, Arutselvan Natarajan, Nan Ring, Richard H. Kimura, Jonathan M. Tsai, Aashish Manglik, Andrew C. Kruse, Sanjiv S. Gambhir, Irving L. Weissman, Aaron M. Ring	2015	288
10	Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling The Journal of Experimental Medicine ·Benjamin Israelow, Eric Song, Tianyang Mao, Peiwen Lu, Amit Meir, Feimei Liu, Mia Madel Alfajaro, Jin Wei, Huiping Dong, Robert Homer, Aaron M. Ring, Craig B. Wilen, Akiko Iwasaki	2020	272
11	A Forward Chemical Genetic Screen Reveals Gut Microbiota Metabolites That Modulate Host Physiology Cell ·Haiwei Chen, Phu-Khat Nwe, Yi Yang, Connor Rosen, Agata A. Bielecka, Manik Kuchroo, Gary W. Cline, Andrew C. Kruse, Aaron M. Ring, Jason M. Crawford, Noah W. Palm Hit paper breakdown →	2019	266
12	IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy Nature ·Ting Zhou, William Damsky, Orr-El Weizman, Meaghan K. McGeary, K. Patricia Hartmann, Connor Rosen, Suzanne Fischer, Ruaidhrí Jackson, Richard A. Flavell, Jun Wang, Miguel F. Sanmamed, Marcus Bosenberg, Aaron M. Ring	2020	248
13	Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity Proceedings of the National Academy of Sciences ·Nan Ring, Dietmar Herndler‐Brandstetter, Kipp Weiskopf, Liang Shan, Jens-Peter Volkmer, Benson M. George, Melanie Lietzenmayer, Kelly M. McKenna, Tejaswitha Jairaj Naik, (unknown), Yunjiang Zheng, Aaron M. Ring, Richard A. Flavell, Irving L. Weissman	2017	247
14	Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients Science Translational Medicine ·Carl A. Pierce, Paula Preston‐Hurlburt, Yile Dai, Clare Burn Aschner, Natalia Cheshenko, Benjamin Galen, S. Garforth, Natalia G. Herrera, Rohit K. Jangra, Nicholas C. Morano, Erika P. Orner, Sharlene Sy, Kartik Chandran, James Dziura, Steven C. Almo, Aaron M. Ring, Marla J. Keller, Kevan C. Herold, Betsy C. Herold	2020	218
15	Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway Proceedings of the National Academy of Sciences ·Pedro San‐Cristobal, Diana Pacheco‐Alvarez, Ciarán Richardson, Aaron M. Ring, Norma Vázquez, Fatema H. Rafiqi, Divya M. Chari, Kristopher T. Kahle, Qiang Leng, Norma A. Bobadilla, Steven Hébert, Dario R. Alessi, Richard P. Lifton, Gerardo Gamba	2009	201
16	Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15 Nature Immunology ·Aaron M. Ring, Jian‐Xin Lin, Dan Feng, Suman Mitra, Mathias Rickert, Gregory R. Bowman, Vijay S. Pande, Peng Li, Ignacio Moraga, Rosanne Spolski, Engin Özkan, Warren J. Leonard, K. Christopher García	2012	181
17	Molecular Physiology of the WNK Kinases Annual Review of Physiology ·Kristopher T. Kahle, Aaron M. Ring, Richard P. Lifton	2007	170
18	Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms Immunity ·Jamie B. Spangler, Jakub Tomala, Vincent C. Luca, Kevin M. Jude, Shen Dong, Aaron M. Ring, Petra Votavová, Marion Pepper, Marek Kovář, K. Christopher García	2015	168
19	Cytokine therapy reverses NK cell anergy in MHC-deficient tumors Journal of Clinical Investigation ·Michele Ardolino, Camillia S. Azimi, Alexandre Iannello, Troy N. Trevino, Lucas H. Horan, Lily Zhang, Weiwen Deng, Aaron M. Ring, Suzanne Fischer, K. Christopher García, David H. Raulet	2014	150
20	An SGK1 site in WNK4 regulates Na ⁺ channel and K ⁺ channel activity and has implications for aldosterone signaling and K ⁺ homeostasis Proceedings of the National Academy of Sciences ·Aaron M. Ring, Qiang Leng, Jesse Rinehart, Frederick H. Wilson, Kristopher T. Kahle, Steven Hébert, Richard P. Lifton	2007	129

About Aaron M. Ring

Aaron M. Ring is a scholar working on Immunology, Molecular Biology, Oncology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 68 papers that have together received 8.9k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), Phagocytosis and Immune Regulation (13 papers), T-cell and B-cell Immunology (12 papers), Cancer Immunotherapy and Biomarkers (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (10 papers) and Ion Transport and Channel Regulation (6 papers). The work is most often cited by research in Immunology (3.8k citations), Oncology (2.2k citations), Molecular Biology (3.6k citations), Cellular and Molecular Neuroscience (829 citations) and Radiology, Nuclear Medicine and Imaging (926 citations). Aaron M. Ring has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Irving L. Weissman, K. Christopher García, Roy L. Maute, Sydney R. Gordon, Andrew C. Kruse, Jonathan M. Tsai, Benson M. George, Melissa McCracken, Aashish Manglik and Gregor Hütter. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature, Cell, eLife and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Aaron M. Ring

Impact in

Papers in i

In The Last Decade

Aaron M. Ring

Aaron M. Ring's Hit Papers

Peers

Countries citing papers authored by Aaron M. Ring

Fields of papers citing papers by Aaron M. Ring

All Works

About Aaron M. Ring

Explore authors with similar magnitude of impact

Papers in